(Q44397622)

English

Effect of orlistat added to diet (30% of calories from fat) on plasma lipids, glucose, and insulin in obese patients with hypercholesterolemia

scientific article published in April 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Effect of orlistat added to diet (30% of calories from fat) on plasma lipids, glucose, and insulin in obese patients with hypercholesterolemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

0 references

hypercholesterolemia

0 references

3

object named as

Gerald M Reaven

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

author name string

Charles P Lucas

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Mark N Boldrin

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

language of work or name

0 references

publication date

1 April 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

91

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

961-964

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900112-7

7 January 2021

Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900112-7

7 January 2021

Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900112-7

7 January 2021

Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Münster study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900112-7

7 January 2021

Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900112-7

7 January 2021

Insulin resistance, glucose intolerance, and hyperinsulinemia. Hypertriglyceridemia versus hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900112-7

7 January 2021

Effect of orlistat-assisted weight loss in decreasing coronary heart disease risk in patients with syndrome X.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900112-7

7 January 2021

Immunoassay of insulin with insulin-antibody precipitate

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900112-7

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900112-7

7 January 2021

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900112-7

7 January 2021

Hypertriglyceridemia as a cardiovascular risk factor

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900112-7

7 January 2021

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900112-7

7 January 2021

Identifiers

10.1016/S0002-9149(03)00112-7

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44397622&oldid=2020980987"